Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer
afatinib
1200.10
NCT00425854
Breast Neoplasms
Phase 2
 
July 2014

Powered by ideaPoint, Inc.